PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Paediatrics, University of Western Australia, Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute and Perth Children\'s Hospital, Perth, WA, Australia.\', \'Linear Clinical Research, Perth, WA, Australia.\', \'Clover Biopharmaceuticals, Chengdu, China.\', \'Global Research in Infectious Diseases, Rio de Janeiro, Brazil. Electronic address: clemens.ralf@outlook.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(21)00241-510.1016/S0140-6736(21)00241-5
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 33524311
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33524311>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33524311>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all